Clinical Trials
Clinical Trials
Recently Added |View All
News
Join Roswell Park Experts at ASCO
Nearly two dozen experts from Roswell Park Comprehensive Cancer Center will be attending this year’s American Society of Clinical Oncology conference in Chicago, May 30-June 3, and we’d like to invite you to meet them.
News
A clinical trial now recruiting at Roswell Park Comprehensive Cancer Center aims to redefine therapeutic stratification and improve outcomes for patients with extensive-stage small cell lung cancer (ES-SCLC).
News
Can Induction Improve Survival in High-Risk, Locally Advanced Cervical Cancer?
Rates of overall and progression-free survival for locally advanced cervical cancer have risen significantly since 2024, when the FDA approved the use of pembrolizumab (brand name Keytruda) with chemoradiation for stage 3-4A disease.
News
Two genetic subtypes of childhood B-cell acute lymphoblastic leukemia (B-ALL) have long been associated with inferior treatment outcomes: Philadelphia chromosome-positive (Ph+) and ABL-class Philadelphia chromosome-like (Ph-like) B-ALL.
Video
A phase 1 clinical trial underway exclusively at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., is evaluating a new chimeric antigen receptor (CAR) T-cell therapy that could dramatically transform the treatment of relapsed ...
Video
New Trial Tests Gabapentin As Treatment for Mucositis, Replacing Opioids
A new trial available at Roswell Park Comprehensive Cancer Center, organized by the Alliance for Clinical Trials in Oncology Foundation, is looking to determine the efficacy of using gabapentin for pain mitigation.
News
Some bone metastases appear to be at higher risk for such complications as pathologic fracture, spinal cord compression, pain or surgery to bone, even if they’re asymptomatic
Video
Roswell Park Offering CAR T Trial for Autoimmune Conditions
While most CAR T-cell therapies and clinical trials are directed at cancers, a new phase 1 trial at Roswell Park Comprehensive Cancer Center is open and recruiting patients with a variety of autoimmune conditions.
Video
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients
While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.
This site is intended for healthcare professionals
RPMD App
Access wherever you go
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
BROADCASTMED